Kenneth Ross is a Professor in the Computer Science Department at Columbia University in New York City. His primary appointment is within the Department of Computer Science, with affiliations including the Foundations of Data Science Committee. His work bridges theoretical database research and practical system implementation. His research focuses on database systems with particular expertise in query processing, query language design, data warehousing, and architecture-sensitive database system design. Additional research spans computational biology, especially analysis of large genomic data sets. Current projects include Linear Algebra Operators in Databases for machine learning workloads and Repeats and Somatic Mutation analysis in genomics. His work consistently addresses the intersection of hardware capabilities and database system design. Ross leads the Database Research Lab at Columbia, which has produced significant work on query optimization, GPU database processing, and hardware-conscious database systems. His recent publications demonstrate strong focus on adapting database systems to modern hardware including GPUs, SIMD processors, and persistent memory. His scientific recognition includes: Packard Foundation Fellowship Sloan Foundation Fellowship NSF Young Investigator Award Distinguished Faculty Teaching Award (2008) Ross actively advises undergraduate engineering students (juniors with last names P-Z) and has taught foundational courses including Introduction to Databases and Programming and Problem Solving for over two decades. His teaching portfolio shows consistent engagement with both theoretical concepts and practical implementation challenges in computer science education.
Dr. Andre Kahles is a Lecturer in the Department of Computer Science at ETH Zürich, specializing in biomedical informatics. His research focuses on computational methods for analyzing large-scale genomic and transcriptomic data, with applications in cancer genomics, metagenomics, and precision medicine. He has contributed to the development of tools such as SplAdder for alternative splicing analysis, MetaGraph for petascale genomic data exploration, and SECEDO for subclone detection in cancer genomes. His work bridges algorithmic innovation with biological insights, addressing challenges in single-cell analysis, genome graph alignment, and multi-omics integration. Key research themes include: Developing scalable algorithms for processing nanopore sequencing and metagenomic data Characterizing somatic mutations and non-coding drivers in cancer genomes Advancing genome graph-based alignment and annotation methods Integrating multi-omics data for clinical decision-making and tumor profiling His publications span topics like RNA-seq analysis, chromothripsis in cancers, and global urban microbiome tracking through the MetaSUB consortium. Kahles has collaborated on landmark projects including the Pan-Cancer Analysis of Whole Genomes (PCAWG) and the Tumor Profiler Study.
Igor Jurisica is a Professor at the University of Toronto and a Senior Scientist at the Krembil Research Institute’s Data Science Discovery Centre for Chronic Diseases. He also serves as Visiting Scientist at IBM CAS, Scientific Director of the World Community Grid, and Chief Scientist at the Creative Destruction Lab (Rotman School of Management). His research focuses on integrative computational biology, data mining, and AI-driven models for cancer mechanisms, drug discovery, and chronic disease management. Key affiliations include the Osteoarthritis Research Program, Schroeder Arthritis Institute, and leadership roles in open science initiatives like the World Community Grid, a global distributed computing platform with 810,000+ volunteers. Jurisica’s work bridges computational tools (e.g., NAViGaTOR visualization platform, MirDIP databases) and clinical applications, emphasizing explainable AI in healthcare. Research interests span proteomics, microRNA regulation, systems vaccinology, and multi-omics integration for disease stratification. Notable contributions include identifying prognostic signatures in cancer and osteoarthritis, machine learning models for drug repurposing, and sportomics analyses of athletic biomarkers. He has been recognized as a Thomson Reuters Highly Cited Researcher (2014-2016) and ranked among the Top 100 AI Leaders in Oncology (2023). His labs develop open-access tools like PathDIP, OsteoDIP, and miRAnno to advance translational research.
Prof. Dr. Susanne Foitzik is a Professor of Evolutionary Biology at Johannes Gutenberg University Mainz since 2010, where she leads the Evolution & Behavioral Ecology of Ants research group at the Institute of Organismic and Molecular Evolution (IOME). Previously, she was Professor in Behavioral Ecology at LMU Munich (2004-2010) and Assistant Professor in Zoology at the University of Regensburg (2000-2004). She earned her PhD in Biology from Julius Maximilian University, Würzburg in 1998. Her research integrates approaches from behavioral ecology through genomics to epigenetics, focusing on ants as model organisms to study complex social behaviors. Host-parasite coevolution and social parasitism in ants Molecular mechanisms underlying division of labor Reversal of the fecundity-longevity trade-off in social insects Gene regulation in phenotypic plasticity Evolution of chemical communication systems Analysis of her recent publications (2022-2025) reveals a strong focus on molecular mechanisms of social behavior, with particular emphasis on host-parasite interactions, epigenetic regulation of behavior, and genomic adaptations in social insects. Her work increasingly combines transcriptomic, proteomic, and functional genomic approaches to understand the molecular basis of social evolution. Among her notable scientific achievements: Speaker of Research Training Group 2626 GenEvo: Gene Regulation in Evolution (2019-present) Speaker of EES Master Program funded by VW foundation (2007-2010) DAAD Fellow at State University of New York (1992-93) Prof. Foitzik has supervised numerous PhD students and postdocs, including Maide Macit, Tom Sistermans, and Marcel Caminer. Her research is supported by multiple DFG-funded projects investigating host-parasite coevolution, the role of gene regulation in division of labor, and parasite interference in host gene expression. She serves as Handling Editor for Biology Letters and previously served on the editorial board of Insectes Sociaux. Her research group operates within the Institute of Organismic and Molecular Evolution (IOME) at Mainz, with laboratory facilities at the Biozentrum I. The group collaborates extensively with researchers across Germany and internationally, including partnerships with institutions in Frankfurt, Freiburg, Bristol, and Tel Aviv.
Ross Thyer is an Assistant Professor in the Department of Chemical and Biomolecular Engineering at Rice University. He holds a BSc (Hons) from the University of Western Australia and a PhD from the Harry Perkins Institute of Medical Research under Drs. Rackham and Filipovska. His postdoctoral training at the University of Texas at Austin with Prof. Andrew Ellington focused on engineered biosynthesis pathways and non-canonical amino acids. He co-founded GRO Biosciences, a Boston-based biotech startup, and leads the Thyer Lab at Rice. His research bridges synthetic biology, protein engineering, and molecular programming to address global challenges. Key areas include expanding genetic codes for therapeutics, engineering biosynthetic pathways via genetic circuitry, and developing microbial systems for environmental bioremediation. Core technologies include deep learning for protein design, modular DNA assembly, and high-throughput selections. The lab also develops tools like MutCompute for enzyme engineering and domesticates non-model bacteria for bioproduction. His work emphasizes technology innovation, with recent advances in selenocysteine incorporation, L-DOPA sensing systems, and actinobacteria toolkits. The Thyer Lab actively collaborates on biocatalyst development and translational applications in healthcare and industry.
Prof. Dr. Soeren Lienkamp is an Assistant Professor at the Institute of Anatomy , Faculty of Medicine , University of Zurich . His work bridges digital education and genetic research , focusing on enhancing medical teaching through innovative formats. Research Interests : Genetics, developmental biology, kidney disease modeling, CRISPR applications, digital medical education, and advanced microscopy. Methodologies : Combines Xenopus tropicalis models, deep learning , and bioengineering to study genetic kidney disorders and improve diagnostic tools. Publication Trends : His recent articles highlight predictable genome editing , 3D imaging technologies , and mechanistic insights into kidney and eye development. Earlier works focus on ciliary function , Wnt signaling , and metabolic stress in renal cells.
Dr. Brent Fogel is a Professor in the Departments of Neurology and Human Genetics at the David Geffen School of Medicine, UCLA. He directs the Neurogenetics Clinic and the UCLA Clinical Neurogenomics Research Center , focusing on diagnosing and managing genetic neurological disorders such as cerebellar ataxia , ataxia with oculomotor apraxia , spastic paraplegia , and leukodystrophies . His research integrates genomics , bioinformatics , and neuroimaging to improve precision medicine in prenatal counseling and rare disease diagnosis. Education: MD, PhD from Medical College of Wisconsin (2003) PhD in Genetics (2001) Internship in Internal Medicine (Northwestern University, 2004) Residency in Neurology (UCLA, 2007) Fellowship in Neurogenetics (UCLA, 2009) Board Certified in Neurology (2009) Research Focus: Dr. Fogel’s work spans neurogenetics , spinocerebellar ataxia , leukodystrophy , and genomic technologies . He has pioneered gene discovery in hereditary ataxias, developed transcriptional biomarkers , and contributed to diagnostic guidelines for rare disorders. His studies on lysosomal genes in Parkinson’s disease and exome sequencing disparities address critical gaps in neurogenetic research. Key Collaborations: He leads multicenter studies with the Ataxia Global Initiative , Undiagnosed Diseases Network , and Genomics England Research Consortium . His lab ( FogelLab ) develops tools like multiWGCNA for gene network analysis.
Prof. Dr. med. Franz Lennard Ricklefs is a Senior Physician and Head of the Working Group at the Department of Neurosurgery, University of Hamburg Faculty of Medicine. He is a Medical Specialist in Neurosurgery with cross-disciplinary expertise in neuro-oncology, molecular pathology, and extracellular vesicle research. Affiliations: University Medical Center Hamburg-Eppendorf (UKE), European Liquid Biopsy Society (ELBS), International Consortium on Meningiomas (ICOM) Research Interests: His work focuses on neurosurgical oncology, particularly glioblastoma and meningioma pathobiology. He investigates DNA methylation patterns, extracellular vesicle biomarkers, and liquid biopsy implementation in clinical neuro-oncology. Additional interests include surgical outcomes for epilepsy and aneurysm management. Article Trends: Over the last decade, Dr. Ricklefs has published extensively on: Extracellular vesicle applications as liquid biopsy markers DNA methylation subclasses for glioblastoma and meningioma Multicenter surgical outcome benchmarking Immune evasion mechanisms in neuro-oncology Technological innovations in neurosurgical visualization Molecular characterization of rare CNS tumors Professional Contributions: He co-authored the MISEV2023 guidelines for extracellular vesicle studies and participates in international consensus reviews for meningioma classification. His collaborations span institutions across Europe and North America.
Philip Boone, MD, PhD, is an Attending Physician in the Division of Genetics and Genomics at Boston Children's Hospital and an Instructor of Pediatrics at Harvard Medical School. He specializes in medical genetics with particular expertise in rare disorders, medical mysteries, deletion and duplication syndromes, and Cornelia de Lange syndrome. Dr. Boone sees patients at Boston Children's Brookline location (2 Brookline Place, 7th Floor) and provides comprehensive genetic care including diagnostics, counseling, and individualized management. Stanford University (Undergraduate, 2006) Baylor College of Medicine (Graduate & Medical School, 2013-2014) Boston Combined Residency Program (Internship & Residency, 2016-2020) Harvard Medical School Genetics Training Program (Fellowship, 2020) Dr. Boone's research focuses on neurodevelopmental disorders, chromatin regulation, and genetic diagnostics. His work spans from fundamental genetic mechanisms to clinical applications, with particular emphasis on cohesinopathies including Cornelia de Lange syndrome. He has contributed significantly to understanding genetic variants associated with growth disorders, developmental features, and structural chromosomal abnormalities. His research combines advanced genomic technologies with clinical insights to improve diagnosis and management of rare genetic conditions. Analysis of Dr. Boone's publication record reveals a strong focus on medical genetics with emphasis on neurodevelopmental disorders, chromatin regulation, and genetic diagnostics. His work spans basic research on gene function and regulation to clinical applications in rare disease diagnosis. A notable trend is his investigation of cohesin complex disorders, particularly SMC3 variants and their relationship to Cornelia de Lange syndrome. His publications demonstrate expertise in both traditional genetic analysis and cutting-edge genomic technologies including long-read sequencing and telomere-to-telomere assembly. Dr. Boone actively contributes to medical education through publications on genetic diagnostics and distance learning resources for medical genetics. He has co-authored educational materials that help advance the field's knowledge base and training capabilities. As an attending physician in the Division of Genetics and Genomics at Boston Children's Hospital and a research fellow in the Center for Genomic Medicine at Massachusetts General Hospital, Dr. Boone works within one of the largest pediatric genetics practices in the country. The division includes over 30 board-certified clinical geneticists, genetic counselors, dieticians, and nursing staff who provide comprehensive care for patients with both common and extremely rare genetic conditions.
Professor David Taubman is a distinguished academic serving as Professor and Deputy Head of School (Research) at the School of Electrical Engineering and Telecommunications (EE&T) at the University of New South Wales (UNSW) in Sydney, Australia. He is also co-director of Kakadu Software Pty. Ltd. and its affiliates Kakadu R&D and Kakadu GPU. With a career spanning over three decades, Professor Taubman has made significant contributions to the field of image and video compression, most notably as the author of the EBCOT coding algorithm adopted in the JPEG2000 international standard. Professor Taubman earned his B.Sc. in Mathematics and Computer Science (1986) and B.E. (Medal) in Electrical Engineering (1988) from the University of Sydney, followed by an M.Sc. (1992) and Ph.D. (1994) in Electrical Engineering from the University of California at Berkeley. His professional journey includes engineering work at the Electricity Commission of N.S.W. (1988-1990), research positions at Hewlett-Packard Laboratories in Palo Alto (1994-1998), and an academic career at UNSW where he progressed from Senior Lecturer (1998-2003) to Associate Professor (2004-2009) and finally to Professor (2009-present). He has held various leadership roles including Head of the EE&T Telecommunications Research Group (2003-2014), Head of the EE&T Signal Processing Research Group (2014-present), Director of Research for the School of EE&T (2011-2016), and Deputy Head of School (Research) since 2017. Professor Taubman's research interests center on image and video compression, with particular expertise in JPEG2000 standards and implementations. His work spans signal processing, wavelet transforms, scalable video coding, motion modeling, and multimedia systems. He has pioneered numerous compression algorithms and frameworks, including the EBCOT coding algorithm that became central to the JPEG2000 standard. His recent research focuses on efficient motion modeling with cuboidal partitioning, learned lifting-based transform structures, and high-throughput implementations of JPEG2000 for video applications. His work bridges theoretical foundations with practical implementations, as evidenced by the commercially successful Kakadu Software tools that have garnered around 500 commercial licensees. Analysis of Professor Taubman's recent publications reveals a consistent focus on advancing compression technologies with particular emphasis on scalability, efficiency, and adaptability. His work spans traditional image compression (JPEG2000 extensions), video coding (cuboid-based partitioning for UHD/360-degree video), and emerging applications (nanopore sequencing data compression). A notable trend is the integration of machine learning techniques with traditional compression frameworks, as seen in his work on learned lifting-based transform structures. His research maintains strong connections to real-world applications across diverse domains including medical imaging, astronomical data processing, and genomic sequencing. IEEE Fellow Engineers Australia Fellow (by invitation) Professor Taubman has served as Associate Editor for the IEEE Transactions on Image Processing for two four-year appointments (2003-2005 and 2010-2013). He has been actively involved in numerous research grants focused on image and video compression technologies, particularly those related to the JPEG2000 standard and its extensions. His work has received significant industry support, reflected in his consultancy with various U.S., Japanese, and Australian corporations. He has also contributed to international standards development as a member of Standards Australia Technical Committee MS-065 (mirroring ISO TC42 on Digital Photography) and as a constitutional member of Standards Australia Technical Committee IT-029 (Coded Representation of Picture, Audio and Multimedia/Hypermedia Information). Professor Taubman co-directs Kakadu Software Pty. Ltd. and its research affiliates Kakadu R&D and Kakadu GPU, which have developed the commercially successful Kakadu Software tools for JPEG2000. His research group at UNSW focuses on advanced image and video compression techniques, with particular expertise in wavelet-based methods, scalable coding, and motion modeling. The group maintains strong industry connections and has contributed significantly to the development and standardization of image compression technologies worldwide.
Xihong Lin is a Professor of Statistics at Harvard University and a Professor of Biostatistics at the Harvard T.H. Chan School of Public Health. She is a distinguished academic, holding membership in both the National Academy of Sciences and the National Academy of Medicine. Her research focuses on scalable statistical inference for big data, statistical machine learning, causal inference, and integrative data analysis, with applications in genomics, public health, and precision medicine. Lin’s work addresses challenges in analyzing large-scale genomic and multi-ancestry data, including methods for rare variant association testing, ancestry-adjusted sample analysis, and scalable computing frameworks. Her contributions span biobank studies (e.g., UK Biobank, TOPMed) and clinical applications in lung cancer, cardiovascular health, and smoking cessation. Her scientific awards reflect her leadership in statistical genetics and public health. Key research trends include leveraging single-cell sequencing for functional genomics, developing ensemble machine learning methods for health subtyping, and enhancing polygenic risk prediction across diverse populations. Lin’s methodologies prioritize interpretability and scalability, enabling impactful analyses of complex observational and genomic datasets. Awards: Member, National Academy of Sciences; Member, National Academy of Medicine Her grants and advising efforts focus on interdisciplinary collaborations, bridging statistics, AI, and domain sciences. Lin leads initiatives to improve genomic data management and ethical use of federated data (e.g., FADI framework). She is affiliated with labs advancing statistical genetics and cloud-based workflows (e.g., STAAR workflow).
Prof. Dr. Sven Panke is a Full Professor and Head of the Department of Biosystems Science and Engineering at ETH Zürich. His research focuses on bioprocess engineering, synthetic biology, and enzymatic process development. Key areas include miniaturized bioreactor systems, microbial engineering for novel metabolite production, and high-throughput screening methodologies. Education: Studied Biotechnology at TU Braunschweig, with postgraduate research at the German National Research Center for Biotechnology and ETH Zurich. Transitioned from industry (DSM) to academia in 2001 as an Assistant Professor, progressing to Associate Professor (2007-2009) before leading the BSS department. Research interests emphasize directed evolution of enzymes, metabolic pathway engineering, and systems biology approaches to optimize microbial production systems. Current projects include bio-indigo synthesis, antimicrobial peptide discovery, and synthetic biology tools for cellular engineering. Labs/Teams: Leads the Bioprocess Engineering Lab at ETH Zurich, collaborating on projects like the E. coli import system design and γ-glutamyltransferase engineering. Active in developing microfluidics platforms for parallel reaction analysis. Grants/Advising: Funded by initiatives in sustainable biomanufacturing and synthetic biology. Supervises graduate students in bioprocess design and microbial systems engineering.
Dr. Andrew Bassett serves as Head of the Cellular and Gene Editing Research group at the Wellcome Sanger Institute, where he develops cutting-edge genome engineering techniques using human pluripotent stem cells to investigate neurodegenerative diseases including Alzheimer's and Parkinson's. His work focuses on scaling genetic screening approaches and improving CRISPR specificity for modeling complex disease mechanisms. His academic training includes: PhD at the MRC Laboratory of Molecular Biology (MRC-LMB) with Andrew Travers on chromatin remodelling in heterochromatin formation Postdoctoral research with David Baulcombe at the University of Cambridge studying small RNA roles in chromatin modification Additional postdoctoral work with Chris Ponting at the MRC Functional Genomics Unit (MRC-FGU) in Oxford, where he pioneered CRISPR applications in Drosophila Bassett's research program centers on developing advanced genome engineering methodologies for precise modulation of gene expression networks during development and neurodegeneration. His group specializes in creating complex editing events (SNPs, paired knockouts, enhancer perturbations) within iPSC-derived models, with particular emphasis on epigenetic regulation and transcriptional control. Current projects integrate single-cell 'omics and phenotypic assays to decode genetic causes of neurodegenerative disorders through the OpenTargets consortium. Analysis of his 15 most recent publications reveals dominant trends in CRISPR technology development (35%), neurodegenerative disease modeling (30%), and single-cell functional genomics (25%). His work consistently bridges methodological innovation with disease mechanism studies, increasingly incorporating multi-omics approaches and expanding into cancer immunology and infectious disease applications since 2022. As group leader, Bassett mentors postdoctoral researchers and PhD students while securing major funding for genome engineering initiatives. His team operates within the Sanger Institute's Cellular Operations division and maintains critical partnerships with the OpenTargets consortium for therapeutic target validation. The laboratory specializes in high-throughput screening platforms using iPSC-derived neural and microglial models, with recent methodological advances including scSNV-seq and ONE-STEP tagging systems that significantly enhance precision genome editing capabilities.
Claudio R. Alarcón is an Associate Professor in Pharmacology at Yale University School of Medicine. His research focuses on RNA metabolism's role in development, health, and disease, particularly RNA modifications and non-coding RNAs. He joined Yale in 2017 after postdoctoral training at The Rockefeller University and holds a PhD from Cornell University (2009) and a BSc from Pontificia Universidad Católica de Chile (1999). Research Interests: Functional roles of m6A RNA modifications MicroRNA biogenesis and cancer progression Non-coding RNA regulation in metastasis Key Appointments: Primary Faculty, Yale Cancer Biology Institute Member, Yale Cancer Center Faculty, Yale Combined Program in Biological and Biomedical Sciences His lab integrates bioinformatics, molecular, and cellular approaches to study cancer metastasis mechanisms, including miRNA processing disruptions and SOX4/TMEM2 pathways linked to clinical outcomes.
Michael Boutros is a Full Professor at Heidelberg University and Head of Division at the German Cancer Research Center (DKFZ). He currently serves as Dean of the Medical Faculty at Heidelberg University (since 2023) and Director of the Marsilius Kolleg (since 2020). He has held leadership roles including Coordinator of the Functional and Structural Genomics Program at DKFZ (2014–2023) and Acting Scientific Director (2015–2016). His academic base is within the Medical Faculty, focusing on molecular oncology and functional genomics. PhD, Witten/Herdecke University (1993–1996) Postdoctoral Research, Harvard Medical School (1999–2003) MPA, John F. Kennedy School of Government, Harvard University (1999–2001) Additional training: Cold Spring Harbor Laboratory, SUNY Stony Brook His research centers on Wnt signaling, functional genomics, and cancer pathways. He leads major research initiatives such as CRC 1324 on Wnt signaling and the ERC Synergy Grant DECODE. His work integrates high-throughput screening, CRISPR, and systems biology to dissect signaling networks in cancer and development. He has pioneered genome-wide RNAi and CRISPR screens to identify novel regulators of Wnt signaling across models. The 15 most recent articles reflect a strong focus on Wnt pathway regulation using functional genomics in both Drosophila and mammalian systems. Themes include high-throughput screening, CRISPR-based validation, cross-species conservation, and therapeutic targeting. Keywords span Cancer Biology, Systems Biology, and Signal Transduction, with subfields like RNAi, ubiquitination, stem cell regulation, and machine learning in image analysis. Michael Boutros has received numerous scientific honors: Elected member, Leopoldina National Academy of Sciences (2022) Elected member, Heidelberg Academy of Sciences (2022) EMBO Member (2013) ERC Advanced Grant (2012) Johann-Georg Zimmermann Research Award (2007) EMBO Young Investigator (2005) Member, 'Die Junge Akademie' (2003) He has been a recipient of the Emmy-Noether Program, McCloy Fellowship, Boehringer Ingelheim PhD Fellowship, Studienstiftung Fellowship, and Fulbright Fellowship. As a mentor and research leader, he has supervised numerous early-career scientists and coordinated large collaborative grants including the FP7 'CancerPathways' project. He currently serves as Speaker of the Research and Strategy Commission at Heidelberg University and Managing Director of the Health and Life Science Alliance Heidelberg Mannheim. He leads the CRC 1324 on Wnt signaling and is Coordinating PI of the ERC Synergy Grant DECODE. He is also Spokesperson of DFG Research Group 1036 and Coordinator of the former FP7 Coordinated Project 'CancerPathways'. His lab employs cutting-edge functional genomics tools to decode signaling networks in cancer and development.
